CEACAM5 and metastatic colorectal cancer: Boogerd et al. 16 used a fluorescent anti-CEA tracer in patients with both primary and metastatic colorectal cancer and demonstrated alterations of surgical strategy based on intraoperative fluorescence imaging in 35% of patients.